14/02/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
February 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
« Jan
Mar »
14/02/2024
Feb 14, 2024, 19:39 |
Drugs
Bishal Gyawali: A pseudo-innovation for which you get to pay more without any added benefits
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "Read…
Feb 14, 2024, 19:34 |
Blog
Robin Tuohy: We look forward to seeing our myeloma friends in the San Diego area at International IMF Regional Community Workshop!
Robin Tuohy, Vice-President of Support Groups at the International Myeloma Foundation, shared International Myeloma Foundation's…
Feb 14, 2024, 18:57 |
Blog
Our annual ICCD2024 event has just started! - SIOPE
European Society for Paediatric Oncology (SIOPE) made the following post on LinkedIn: “It's finally happening! Our…
Feb 14, 2024, 18:56 |
Blog
Melanie Sisk: We are looking for volunteers who want to make a tangible impact in the lives of patients whose cancer has the PIK3CA mutation
Melanie Sisk, Metastatic Breast Cancer Patient Advocate, shared on X/Twitter: "Hello PIK3CA members. We are looking…
Feb 14, 2024, 18:37 |
Blog
Naveen Pemmaraju: Important brainstorming sessions today with Team Pemm for new ideas in MPNSM & BPDCN!
Naveen Pemmaraju shared on X: “Important brainstorming sessions today with Team Pemm for new ideas…
Feb 14, 2024, 18:13 |
Drugs
Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 - Oncology Brothers
Oncology Brothers made the following post on X: "Liposomal Irinotecan now FDA Oncology approved for…
Feb 14, 2024, 18:02 |
Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Feb 14, 2024, 17:54 |
Blog
This commentary by Donald Harvey et al. is a call to action for a concerted commitment to transform clinical trials - ACS Journal Cancer
ACS Journal Cancer posted on X: “This commentary by Donald Harvey et al. is a…
Feb 14, 2024, 17:42 |
Blog
Lynn Schuchter: Please work with your colleagues to mitigate these drug shortages
Lynn Schuchter recently shared on X: “Drug shortages are impacting thousands of individuals w/ cancer, including…
Feb 14, 2024, 14:59 |
Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
1
2
3
All:
25
Posts:
1 - 10
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube